[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent. - Wikidata - awgldk - TriplyDB

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

http://www.wikidata.org/entity/Q34473613

about

Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents (11)C[double bond, length as m-dash]O bonds made easily for positron emission tomography radiopharmaceuticals PET Metabolic Biomarkers for Cancer Imaging tumor metabolism using positron emission tomography Metabolic pathways promoting cancer cell survival and growth De Novo Glutamine Synthesis: Importance for the Proliferation of Glioma Cells and Potentials for Its Detection With 13N-Ammonia.Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer The Potential of Metabolic Imaging.Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.Metabolic Imaging of Glutamine in Cancer.Engineering Tumour Cell-Binding Synthetic Polymers with Sensing Dense Transporters Associated with Aberrant Glutamine Metabolism.Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias.Imaging Cancer Metabolism.Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In Vivo.

P2860

Q26740567-F81D4E6C-2980-4421-A41B-52A527563F33 Q28066107-844A9F24-F8C8-48EE-ABD7-011A846A71C2 Q28074449-948BFA10-5322-41F2-95E3-3A164E9B40D1 Q28085278-9A028DA6-9712-452C-97B3-45C7CF6DDEF0 Q28086940-313A787C-2A08-4D46-A70B-560478399AC1 Q33795471-FCB3844C-98DD-45CB-A89B-1D693924A8E3 Q36279031-A43E078F-FB3A-4874-A20D-B5C2B0D16C56 Q36392626-14560A2A-D0DD-48CF-B2E8-B362B54CB0B8 Q36858702-4AA3EBEA-C023-4144-836B-1AE6924647E0 Q38838285-FA97065B-F834-4F7D-A8CF-D0D1D4DD0965 Q39148570-05534219-B76A-41A7-A562-F9C62D3E9AF4 Q41075531-C51F1A4D-19AE-4FF4-B52C-AD2698CE2506 Q45059950-0CF645B1-68B9-4078-B9D9-9E19025B8295 Q47117264-DD4E7537-C7AB-41B7-BB69-B94105BA3280 Q51129176-629A8638-62B3-40A6-93B7-660C59E51E34

P2860

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

http://www.wikidata.org/entity/Q34473613

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@ast

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@en

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@nl

type

label

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@ast

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@en

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@nl

prefLabel

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@ast

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@en

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@nl

P1433

Q34473613-E1ABFDB5-A460-44A9-B4E7-EDF05856ABD2

P1476

Q34473613-EE9E0957-8642-401D-94E6-FBB761527ECB

P2093

Q34473613-168E25D8-24D8-4DBA-A98F-AC650AE9AEB1

Q34473613-50FC0B57-178F-49A9-9A21-27D7E660A9B2

Q34473613-6FE41C4F-6054-4C1D-933F-C4066BAEA329

Q34473613-842AB816-9458-48DA-B7ED-1D8D6AABFB3C

Q34473613-BB441A30-D77D-4BA2-83B2-49234FD0AD62

Q34473613-D7207CB0-98F1-49DA-8541-1E1AFAC1E31C

Q34473613-F82EEA44-8F0A-43F0-ACF1-403DE318AC27

P2860

Q34473613-0D0C214F-DDB2-4B1A-B8A3-221F7BD27704

Q34473613-15C062FA-F6FD-4299-8D9C-6311F73387E8

Q34473613-1D8C5376-8FA9-4F7B-9005-B0AD7604F755

Q34473613-1F8E8998-8FB9-4842-AF14-85D9A03A617C

Q34473613-260EDDAC-50BA-4045-A1C4-77847A5A54C8

Q34473613-2B9D8BC1-7B76-4920-B199-F3EDA37B2FE8

Q34473613-2BAB9657-1F2C-4C4F-B8AB-FC3A31B09033

Q34473613-2FBE612C-68A8-4E88-BE12-63EE046B7236

Q34473613-330C32BB-A694-4926-AB4C-2A367D8C002A

Q34473613-4D3AF727-F313-4379-AE0B-DD2471CCC534

P304

Q34473613-2D0D6322-0D59-4756-8DFF-1CEA9C5B6C68

P31

Q34473613-3F3FD02D-D118-4FEF-8762-1B3EB3FFD10F

P356

Q34473613-46DE93FF-5B4E-41B0-946A-530555E9D4B8

P407

Q34473613-AA09A30B-0987-49CC-B26B-A63318BD212C

P433

Q34473613-6ECA5D1C-D5F9-44B6-BB35-E820DC9D5B1F

P478

Q34473613-C1721BD9-B214-49A0-948A-91F6371985DB

P577

Q34473613-9FEA82E1-0FDC-4E09-941D-495413B296D4

P5875

Q34473613-F359FE03-547B-450F-9D15-27BEE3C25BF5

P698

Q34473613-49868187-D859-457E-B28C-F784EBB73A65

P932

Q34473613-617489AE-A2D7-4D10-8468-EAC21088D388

P356

P1433

Molecular Pharmaceutics

P1476

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

@en

P2093

Brian P Lieberman

http://www.w3.org/2001/XMLSchema#string

Genxun Li

http://www.w3.org/2001/XMLSchema#string

Hank F Kung

http://www.w3.org/2001/XMLSchema#string

Karl Ploessl

http://www.w3.org/2001/XMLSchema#string

Seok Rye Choi

http://www.w3.org/2001/XMLSchema#string

Zehui Wu

http://www.w3.org/2001/XMLSchema#string

Zhihao Zha

http://www.w3.org/2001/XMLSchema#string

P2860

Radiolabeled amino acids for oncologic imaging

Identification of the promoter elements involved in the stimulation of ASCT2 expression by glutamine availability in HepG2 cells and the probable involvement of FXR/RXR dimers

Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells

Otto Warburg's contributions to current concepts of cancer metabolism

Glutamine addiction: a new therapeutic target in cancer

Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis

Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT

Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

Therapeutic targeting of cancer cell metabolism.

The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.

P304

3852-3866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP500236Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264538736

http://www.w3.org/2001/XMLSchema#string

P698

25095908

http://www.w3.org/2001/XMLSchema#string

P932

4224545

http://www.w3.org/2001/XMLSchema#string